194 related articles for article (PubMed ID: 33594690)
1. Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.
Jeong Y; Lee KJ; Lee SJ; Shin YM; Kim MJ; Lim YS; Lee HC; Jung J; Park JH; Kim JH; Kim SY; Yoon SM
J Gastroenterol Hepatol; 2021 Jul; 36(7):1962-1970. PubMed ID: 33594690
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma.
Shin HS; Hwan Lee S; Jun BG; Kim HS; Kang SH; Park JY; Choi SI; Cheon GJ; Kim YD; Yoo JJ; Kim SG; Kim YS; Jeong SW; Jang JY; Suk KT; Kim DJ; Jo IY; Won YK
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1187-1194. PubMed ID: 36170689
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
5. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: a meta-analysis.
Zhang H; Chang N; Han T; Ma S; Qu G; Liu H; Sun C; Cheng C; Zhou Q; Sun Y
Future Oncol; 2021 Oct; 17(30):4027-4040. PubMed ID: 34278818
[TBL] [Abstract][Full Text] [Related]
7. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Wang L; Ke Q; Huang Q; Shao L; Chen J; Wu J
Int J Hyperthermia; 2020; 37(1):1313-1321. PubMed ID: 33243024
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.
Jackson WC; Tao Y; Mendiratta-Lala M; Bazzi L; Wahl DR; Schipper MJ; Feng M; Cuneo KC; Lawrence TS; Owen D
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):950-958. PubMed ID: 29485074
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases.
Yu J; Kim DH; Lee J; Shin YM; Kim JH; Yoon SM; Jung J; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim SY; Kim JE; Park JH; Kim SY
Cancer Res Treat; 2022 Jul; 54(3):850-859. PubMed ID: 34645129
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis.
Facciorusso A; Chierici A; Cincione I; Sacco R; Ramai D; Mohan BP; Chandan S; Ofosu A; Cotsoglou C
Expert Rev Anticancer Ther; 2021 Jun; 21(6):681-688. PubMed ID: 33590783
[No Abstract] [Full Text] [Related]
12. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ji R; Ng KK; Chen W; Yang W; Zhu H; Cheung TT; Chiang CL; Wong TCL; Kong FM; Wu G; Lo CM
Medicine (Baltimore); 2022 Jan; 101(4):e28545. PubMed ID: 35089192
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression.
Malik A; Jairam MP; Chow R; Mirshahvalad SA; Veit-Haibach P; Simone CB
Future Oncol; 2023 Feb; 19(4):279-287. PubMed ID: 36916490
[No Abstract] [Full Text] [Related]
14. Stereotactic body radiation therapy versus radiofrequency ablation in hepatocellular carcinoma: an up-date meta-analysis.
Yang D; Lin K; Wang Y; Xie X; Xie X; Zhuang B
Abdom Radiol (NY); 2023 Jan; 48(1):399-410. PubMed ID: 36287228
[TBL] [Abstract][Full Text] [Related]
15. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
[TBL] [Abstract][Full Text] [Related]
16. Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.
Wang F; Numata K; Takeda A; Ogushi K; Fukuda H; Nihonmatsu H; Hara K; Chuma M; Tsurugai Y; Maeda S
BMC Cancer; 2021 Oct; 21(1):1169. PubMed ID: 34717577
[TBL] [Abstract][Full Text] [Related]
17. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
18. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.
Lee J; Shin IS; Yoon WS; Koom WS; Rim CH
Radiother Oncol; 2020 Apr; 145():63-70. PubMed ID: 31923711
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
